Research Use Only. Not medical advice. Investigational compound. Slow titration is critical — cumulative GI burden in combination with GLP agents requires careful monitoring.
Cagrilintide Protocol Reference
Joseph physician practice titration framework, GLP combination context, and cycle guidance.
Sourced Protocol Frameworks
Source: Joseph Physician Practice ProtocolProtocol philosophy: Start lowest source-supported dose. Slow titration over months is critical for GI tolerability. Cumulative GI burden in combination must be assessed continuously.
WEEK 1–40.1 mg SC weekly. Joseph starting dose — very low initiation for GI tolerance. Assess before escalating.
WEEK 5–80.25 mg SC weekly. First escalation step if tolerating well.
WEEK 9–120.5 mg SC weekly. Continue escalation only if well-tolerated.
TARGET1.0–1.5 mg SC weekly. Joseph target range. Slow titration is essential. Clinical development programs study higher doses — not a physician practice target.
Reconstitution Reference
Calculation Example — 5 mg Vial
VIAL CONTENT
5 mg
DILUENT
Bacteriostatic water
EXAMPLE VOLUME
5.0 mL BAC water
CONCENTRATION
1 mg/mL
1 mg DOSE
1.0 mL = 100 units U-100
STORAGE
Refrigerated 4°C
⚠ Arithmetic example only. No approved reconstitution standard. Actual preparation depends on specific vial strength.
Cycle & Reassessment
| Parameter | Framework | Source |
|---|---|---|
| Clinical convention | Ongoing weekly — no established on/off cycle | Phase III program |
| GI monitoring | Critical — especially during titration and in combination | Protocol safety |
| Reassessment | Regular throughout titration period | Protocol philosophy |
Pairing & Sequencing
| Compound | Relationship | Sequencing |
|---|---|---|
| Tirze | GLP combination — amylin + GIP/GLP-1 | Cumulative GI burden consideration |
| Reta | Triple agonist alternative | Choose one GLP-class agent |
Evidence Status
| Category | Status |
|---|---|
| Overall | Investigational — Phase II/III |
| Phase II | Dose-dependent weight loss demonstrated |
| CagriSema Phase III | Program ongoing — outcomes pending |
| WADA status | Prohibited |
Source Cagrilintide at Forge Scientific
Third-party tested, HPLC + Mass Spec verified, lot-specific COA. Ships same day — Fort Worth, TX.